crispr therapeutics, mgh team up on new cancer treatments
.
“it may be just out of an abundance of caution and privacy. certainly, staying a little longer may imply that this is a little bit more of a complex situation.”
.
.
harvard medical school: "cgrp: a new era for migraine treatment."
.
the report was compiled by outside researchers who went into the fda�s own database of �serious adverse [medical-drug] events.�
. the software identified and measured a marker of svd and then gave a score indicating how severe the disease was ranging from mild to severe.
.